Overview
Molecule is the infrastructure layer of decentralized science, providing the IP-NFT framework that underpins most biotech DAOs. The platform lets research communities fund biomedical research and trade the resulting intellectual property on-chain, turning years of locked, illiquid scientific output into assets with price discovery and secondary markets.
Molecule's core innovation is attaching legal IP rights to an NFT, creating an asset class that a community can co-own and govern. The platform spans longevity, brain health, women's health, psychedelics, cell therapy and climate research, and is the tokenization engine behind the Bio Protocol BioDAO ecosystem.
How IP-NFTs and IP Tokens work
An IP-NFT is a single non-fungible token that carries the legal rights to a research project — its data, licensing terms and any downstream commercial upside. Molecule's open-source IP-NFT contracts reached V2 in 2024, standardizing this as reusable building blocks for the DeSci economy.
A single NFT is a poor governance and funding instrument, so Molecule adds a Tokenizer contract that mints an ERC-20 IP Token (IPT) against an IP-NFT. Fractionalizing the IP-NFT into IPTs distributes ownership across many holders, funds the research through their purchases, and lets that group of holders collectively govern the asset as it moves through the R&D pipeline. IPTs can also gate access to proprietary data and route IP-licensing revenue back to holders.
This is the on-chain analogue of a cap table for a research program — a design that sits squarely inside the DAO tokenomics question of how a token confers real economic and governance rights rather than pure speculation. In 2025 Molecule extended the model toward bridging tokenized IP into the wider real-world-asset (RWA) market.
IP as a treasury asset
For a science DAO, the tokenized IP is not a side product — it is the treasury's core holding. A VitaDAO or AthenaDAO funds a study, receives an IP-NFT, and that asset (plus any licensing income) is what the community stewards. This makes treasury management for a DeSci DAO a question of managing a portfolio of illiquid, high-variance research bets rather than a stack of liquid tokens, and it is why the Molecule + Bio Protocol stack pairs IP tokenization with a launchpad and staking layer that keeps the community funding and curating the pipeline.
Products
IP Token trading: the core platform at labs.molecule.xyz enables trading of fractionalized IP tokens derived from IP-NFTs.
IPNFT Explorer & DeSci Screener: discovery and market-analysis tools for browsing on-chain research IP and evaluating IP-token markets.
Documentation: developer and concept guides at docs.molecule.xyz, with the contracts maintained at github.com/moleculeprotocol/IPNFT.
How Caper approaches this
Molecule solves the asset side of DeSci — making research IP ownable and tradable. A caper addresses the organization side: it folds the fundraise (a bonding-curve sale), the treasury, on-chain proposals (PAYOUT / INVEST / VOTE) and an always-available, participation-weighted pro-rata exit into one primitive. A research community could hold its Molecule IP-NFT inside a caper's treasury and let members fund, direct and exit the project through a single contract rather than stitching together a token sale, a multisig and a separate governance tool.